Name: Jennah Ricci J.

Tuazon
Clinical Instructor: Mam Faye D. Coquinco

DRUG ORDER
MECHANISM OF
ACTION
INDICATIONS CONTRAINDICATIONS ADVERSE EFFECT
NURSING
RESPONSIBILITY
PRECAUTIONS
Cefuroxime 375
mg TIV Q8































Interferes with all
bacterial cell-wall
synthesis and
division by binding
to cell wall, causing
cell to die. Active
against gram-
negative and gram-
positive bacteria,
with expanded
activity against
gram-negative
bacteria. Exhibits
minimal
immunosuppressant
activity.
> Moderate to
severe infections,
including those of
skin, bone, joints,
urinary or
respiratory tract,
gynecologic
infection
> Gonorrhea
>Bacterial
meningitis
>Otitis media
>Pharynigits;
tonsilitis

>Hypersensitivity to
cephalosporins or
penicillins
>Carnitine deficiency
>CNS: headache,
hyperactivity,
hypertonia, seizures
>GI: nausea,
vomiting, diarrhea,
abdominal pain,
dyspepsia,
pseudomembranous
colitis
>GU: hematuria,
vaginal candidiasis,
renal dysfunction,
acute renal failure
>Hematologic:
hemolytic anemia,
aplastic anemia,
hemorrhage
>Hepatic: hepatic
dysfunction
>Metabolic:
hyperglycemia
>Skin: toxic
epidermal necrolysis,
erythema multiforme,
Stevens-Johnson
syndrome
>Other: allergic
reaction, drug fever,
superinfection,
anaphylaxis
>Monitor patient for
life-threatening
adverse effects,
including
anaphylasxis,
Stevens-Johnson
syndrome, and
pseudomembranous
colitis
>Monitor neurologic
status, particularly
for signs of
impending seizures
>Monitor liver and
kidney function test
results and intake
and output
>Monitor CBC w/
differential and
prothrombin time;
watch for s/s of
blood dyscrasias
>Monitor temp;
watch for s/s of
superinfection
Salbutamol neb
Q2





































Relaxes smooth
muscles by
stimulating beta
2
-
receptors, thereby
causing
bronchodilation and
vasodilation
>To prevent and
relieve
bronchospasm in
patients with
reversible
obstructive airway
disease
>To prevent
exercise-induced
bronchospasm
>Hypersensitivity to drug >CNS: dizziness,
excitement, headache,
hyperactivity,
insomnia
>CV: hypertension,
palpitations,
tachycardia, chest
pain
>EENT:
conjunctivitis, dry
and irritated throat,
pharyngitis
>GI: nausea,
vomiting, nausea,
anorexia, heart-burn,
GI distress, dry
mouth
>Metabolic:
hypokalcemia
>Musculoskeletal:
muscle cramps
>Respiratory: cough,
dyspnea, wheezing,
paradoxical
bronchospasm
>Skin: pallor,
urticaria, rash,
angioedema, flushing,
sweating
>Other: tooth
discoloration,
increased appetite,
hypersensitivity
reaction
>Stay alert for
hypersensitivity
reactions and
paradoxical
bronchospasm. Stop
drug immediately if
these occur
>monitor serum
electrolyte levels
Budesonide neb
Q12





































Decreases
inflammation by
inhibiting migration
of inflammatory
mediators to injury
site. Where it
reverses dilation and
increases vessel
permeability. Also
decreases plasma
exudation and
mucus secretions
within airway


























>Maintenance
treatment of
asthma as
prophylactic
therapy
>Seasonal or
perennial allergic
rhinitis
>Mild to moderate
active Chron's
disease involving
ileum, ascending
colon, or both


























>Hypersensitivity to drug
>Status asthmaticus





































>CNS: headache,
nervousness,
depression, euphoria,
psychoses, increased
intracranial pressure
>CV: hypertension,
Churg-Strauss
syndrome,
thrombophlebitis,
thromboembolism
>EENT: cataracts,
nasal congestion,
nasal burning or
dryness, epistaxis,
perforated nasal
septum, hoarseness,
nasopharyngeal and
oropharyngeal fungal
infections
>GI: nausea,
vomiting, peptic
ulcers, anorexia,
esophageal
candidiasis, dry
mouth
>Metabolic:
hyperglycemia,
decreased growth(in
children), cushingoid
appearance, adrenal
suppression
Musculoskeletal:
muscle wasting,
muscle pain,
osteoporosis, aseptic
joint necrosis
>Respiratory: cough,
wheezing, rebound
congestion,
>Monitor
respiratory status to
evaluate drug
efficacy
>Stay alert for
hypersensitivity
reactions, especially
angioedema
>Evaluate liver
function test results
>Periodically
observe patient for
proper inhaler use
>Assess oral cavity
for infection








































HAA 45 mg TIV
Q6

















Suppresses
inflammatory and
immune responses,
mainly by inhibiting
migration of
leukocytes and
phagocytes and
decreasing
inflammatory
mediators
















>Replacement
therapy in
adrenocortical
insufficiency;
hypercalcemia due
to cancer; arthritis,
collagen diseases;
dermatologic
diseases;
autoimmune and
hematologic
disorders;
trichinosis;
ulcerative colitis,
multiple sclerosis,
proctitis, nephritic
syndrome;
aspiration
pneumonia
>Itching and
inflammation
caused by skin
conditions
















>Hypersensitivity to
drug, alcohol bisulfites,
or tartrazine (with some
products)
>Systemic fungal
infections
>Concurrent use of other
immunosuppressant
corticosteroids
>Concurrent
administration of live-
virus vaccines

bronchospasm
>Skin: facial edema,
rash, petechiae,
contact dermatitis,
acne, bruising,
hirsutism, urticaria
>Other: bad taste,
ansomia, weight gain
or loss, increased
susceptibility to
infection,
angioedema,
hypersensitivity
reaction


> CNS: headache,
nervousness,
depression, euphoria,
personality changes,
psychoses, vertigo,
paresthesia,
insomnia,
restlessness, conus
medullaris syndrome,
meningitis, increased
intracranial pressure,
seizures
>CV: hypotension,
hypertension,
thrombophlebitis,
heart failure, shock,
fat embolism,
thromboembolism,
arrhythmias
>EENT: cataracts,
glaucoma, increased
intraocular pressure,
epistaxis, nasal
















>In high-dose
therapy(not to
exceed 48 hours),
watch closely for s/s
of depression or
psychotic episodes
>Monitor BP, wt,
and electrolyte levels
regularly
>Assess blood
glucose levels in
diabetic patients.
Expect to increase
insulin or oral
hypoglycemic dosage
>Monitor patient's
response during
weaning from drug.
Watch for adrenal
crisis, which may
occur if drug is
discontinued, too
quickly
congestion,
perforated nasal
septum, dysphonia,
hoarseness,
nasopharyngeal or
oropharyngeal fungal
infections
>GI: nausea,
vomiting, esophageal
candidiasis or ulcer,
abdominal distention,
dry mouth, rectal
bleeding,
pepticulceration,
pancreatitis
>Hematologic:
purpura
>Metabolic: sodium
and fluid retention,
hypokalemia,
hypocalcemia,
hyperglycemia,
hypercholesterolemia,
amenorrhea, growth
retardation, diabetes
mellitus, cushingoid
appearance,
hypothalamic-
pituitary-adrenal
suppression with
secondary adrenal
insufficiency (with
abrupt withdrawal or
high-dose, prolonged
use)
>Musculoskeletal:
osteoporosis, aseptic
joint necrosis, muscle
pain or weakness,
steroid myopathy,
loss of muscle mass,
tendon rupture,
spontaneous fractures
>Respiratory: cough,
wheezing, rebound
congestion,
bronchospasm Skin:
rash, pruritus,
urticaria, contact
dermatitis, acne,
bruising, hirsutism,
petechiae, striae,
acneiform, lesions,
skin fragility and
thinness, angioedema